These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 14565760)
1. Reactivity with Tris(hydroxymethyl)aminomethane confounds immunodetection of acrolein-adducted proteins. Burcham PC; Fontaine FR; Petersen DR; Pyke SM Chem Res Toxicol; 2003 Oct; 16(10):1196-201. PubMed ID: 14565760 [TBL] [Abstract][Full Text] [Related]
2. Differences in lysine adduction by acrolein and methyl vinyl ketone: implications for cytotoxicity in cultured hepatocytes. Kaminskas LM; Pyke SM; Burcham PC Chem Res Toxicol; 2005 Nov; 18(11):1627-33. PubMed ID: 16300370 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct. Maeshima T; Honda K; Chikazawa M; Shibata T; Kawai Y; Akagawa M; Uchida K Chem Res Toxicol; 2012 Jul; 25(7):1384-92. PubMed ID: 22716039 [TBL] [Abstract][Full Text] [Related]
4. Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity. Burcham PC; Fontaine FR; Kaminskas LM; Petersen DR; Pyke SM Mol Pharmacol; 2004 Mar; 65(3):655-64. PubMed ID: 14978244 [TBL] [Abstract][Full Text] [Related]
5. Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice. Kaminskas LM; Pyke SM; Burcham PC J Pharmacol Exp Ther; 2004 Sep; 310(3):1003-10. PubMed ID: 15131244 [TBL] [Abstract][Full Text] [Related]
6. Michael addition of acrolein to lysinyl and N-terminal residues of a model peptide: targets for cytoprotective hydrazino drugs. Kaminskas LM; Pyke SM; Burcham PC Rapid Commun Mass Spectrom; 2007; 21(7):1155-64. PubMed ID: 17318925 [TBL] [Abstract][Full Text] [Related]
7. Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection. Burcham PC; Pyke SM Mol Pharmacol; 2006 Mar; 69(3):1056-65. PubMed ID: 16368895 [TBL] [Abstract][Full Text] [Related]
8. Quantitation of acrolein-protein adducts: potential biomarker of acrolein exposure. Li H; Wang J; Kaphalia B; Ansari GA; Khan MF J Toxicol Environ Health A; 2004 Mar; 67(6):513-24. PubMed ID: 14742096 [TBL] [Abstract][Full Text] [Related]
9. Intermolecular protein cross-linking during acrolein toxicity: efficacy of carbonyl scavengers as inhibitors of heat shock protein-90 cross-linking in A549 cells. Burcham PC; Raso A; Thompson C; Tan D Chem Res Toxicol; 2007 Nov; 20(11):1629-37. PubMed ID: 17907782 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody against protein-bound glutathione: use of glutathione conjugate of acrolein-modified proteins as an immunogen. Furuhata A; Honda K; Shibata T; Chikazawa M; Kawai Y; Shibata N; Uchida K Chem Res Toxicol; 2012 Jul; 25(7):1393-401. PubMed ID: 22716076 [TBL] [Abstract][Full Text] [Related]
11. Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine/acrolein adducts by electrospray ionization tandem mass spectrometry. Carini M; Aldini G; Beretta G; Arlandini E; Facino RM J Mass Spectrom; 2003 Sep; 38(9):996-1006. PubMed ID: 14505328 [TBL] [Abstract][Full Text] [Related]
12. Models of protein modification in Tris-glycine and neutral pH Bis-Tris gels during electrophoresis: effect of gel pH. Hachmann JP; Amshey JW Anal Biochem; 2005 Jul; 342(2):237-45. PubMed ID: 15935323 [TBL] [Abstract][Full Text] [Related]
13. Generation of antibodies to Di- and trichloroacetylated proteins and immunochemical detection of protein adducts in rats treated with perchloroethene. Pähler A; Birner G; Parker J; Dekant W Chem Res Toxicol; 1998 Sep; 11(9):995-1004. PubMed ID: 9760273 [TBL] [Abstract][Full Text] [Related]
14. Actin Cys374 as a nucleophilic target of alpha,beta-unsaturated aldehydes. Dalle-Donne I; Carini M; Vistoli G; Gamberoni L; Giustarini D; Colombo R; Maffei Facino R; Rossi R; Milzani A; Aldini G Free Radic Biol Med; 2007 Mar; 42(5):583-98. PubMed ID: 17291982 [TBL] [Abstract][Full Text] [Related]
15. Immunochemical detection of quinol--thioether-derived protein adducts. Kleiner HE; Rivera MI; Pumford NR; Monks TJ; Lau SS Chem Res Toxicol; 1998 Nov; 11(11):1283-90. PubMed ID: 9815188 [TBL] [Abstract][Full Text] [Related]
16. Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): characterization of conjugation products by ESI-MSn and theoretical calculations. Beretta G; Arlandini E; Artali R; Anton JM; Maffei Facino R J Pharm Biomed Anal; 2008 Jul; 47(3):596-602. PubMed ID: 18378108 [TBL] [Abstract][Full Text] [Related]
17. Protein modification by acrolein: formation and stability of cysteine adducts. Cai J; Bhatnagar A; Pierce WM Chem Res Toxicol; 2009 Apr; 22(4):708-16. PubMed ID: 19231900 [TBL] [Abstract][Full Text] [Related]
18. Competitive binding of a Tris run buffer with chiral crown ether in chiral capillary electrophoresis. Cho SI; Jung H; Chung DS Electrophoresis; 2000 Nov; 21(17):3618-24. PubMed ID: 11271479 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of plasma alpha 1-proteinase inhibitor by acrolein: adduct formation with lysine and histidine residues. Gan JC; Ansari GA Mol Toxicol; 1989; 2(3):137-45. PubMed ID: 2518664 [TBL] [Abstract][Full Text] [Related]
20. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue. Liu X; Lovell MA; Lynn BC Anal Chem; 2005 Sep; 77(18):5982-9. PubMed ID: 16159131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]